Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Group 1 - Collegium Pharmaceutical, Inc. will report its fourth quarter and full-year 2024 financial results on February 27, 2025, after market close [1] - A live conference call and webcast will follow the financial results release at 4:30 p.m. ET [1] - The conference call can be accessed via specific dial-in numbers for U.S. and international participants [2] Group 2 - Collegium is focused on building a diversified biopharmaceutical company with a strong portfolio in pain management and a recent acquisition in neuropsychiatry [3] - The company aims to grow its commercial portfolio, with Jornay PM identified as the lead growth driver [3] - Collegium is committed to disciplined capital deployment to support its strategic initiatives [3]